Allylaminoesters and their application in therapeutics
    4.
    发明授权
    Allylaminoesters and their application in therapeutics 失效
    烯丙基氨基酯及其在治疗中的应用

    公开(公告)号:US5472970A

    公开(公告)日:1995-12-05

    申请号:US309004

    申请日:1994-09-19

    摘要: Allylaminoesters of the formula (I): ##STR1## in which: R.sub.1 is H or low-molecular-weight alkyl,R.sub.2 is low-molecular-weight alkyl, cycloalkyl, or low-molecular-weight phenylcycloalkyl, pyridyl or phenyl, low-molecular-weight phenylalkyl, low-molecular-weight diphenylalkyl, low-molecular-weight phenylalkenyl, in which the phenyl cycle may be mono-, di- or trisubstituted by chlorine atoms, low-molecular-weight alkyl radicals, low-molecular-weight alkoxy, or trifluoromethyl, acetamide or acetyloxy radicals, their racemic forms, their (S) enantiomers and their addition salts. Also, antiallergic drugs containing the same.

    摘要翻译: 式(I)的烯丙基氨基酯:其中:R 1是H或低分子量烷基,R 2是低分子量烷基,环烷基或低分子量苯基环烷基,吡啶基或苯基 ,低分子量苯基烷基,低分子量二苯基烷基,低分子量苯基烯基,其中苯基周期可以被氯原子单,二或三取代,低分子量烷基,低分子量苯基烷基, 分子量的烷氧基或三氟甲基,乙酰胺或乙酰氧基,它们的外消旋体,它们的(S)对映体及其加成盐。 而且,含有相同的抗过敏药物。